Doxazosin
Product Images NDC 70934-366

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 70934-366). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 362 30 Rev A 05 19)

Doxazosin Tablets, USP 4mg, packaged in a carton containing 30 tablets. The label indicates prescription only (Rx Only) with dosage and storage instructions referencing USP standards. The product is labeled by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The National Drug Code (NDC) is 70934-362-30.*

FDA Label Image

Label (70934 366 30 Rev A 05 19)

Doxazosin Tablets USP 8 mg bottle label from Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label indicates the product contains 30 tablets, is Rx only, and provides storage instructions along with batch and NDC information.*

FDA Label Image

Table 1 (Doxazosin Fig1)

A table titled "SUMMARY OF EFFECTIVENESS DATA IN PLACEBO CONTROLLED TRIALS" presenting symptom scores and maximum flow rate for Doxazosin and placebo in three different studies. It shows baseline and mean change values for symptom scores and maximum flow rate, comparing placebo with Doxazosin at varying doses. The table includes footnotes explaining the questionnaires and study conditions alongside a bar graph visually comparing symptom score and maximum flow rate changes in Study 2 for placebo and Doxazosin 4 mg and 8 mg doses.*

FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

Two line graphs showing the effect of Doxazosin compared to placebo over 14 weeks. The left graph depicts mean change in total symptom score from baseline, with Doxazosin showing a greater reduction than placebo. The right graph shows mean increase in maximum urinary flow rate from baseline, where Doxazosin demonstrates a higher increase than placebo. Sample sizes are 50 for Doxazosin and 47 for placebo.*

FDA Label Image

Chemical Structure (Doxazosin Str)

Chemical structure of Doxazosin mesylate, showing the molecular arrangement of its atoms including methoxy groups, piperazine ring, and quinazoline moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.